Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Sight Sciences, Inc. - Common Stock (NQ:SGHT)

3.270 +0.070 (+2.19%)
Streaming Delayed Price Updated: 10:02 AM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,924
Open 3.250
Bid (Size) 3.210 (2)
Ask (Size) 3.330 (1)
Prev. Close 3.200
Today's Range 3.250 - 3.380
52wk Range 2.030 - 6.290
Shares Outstanding 48,460,154
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures
UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate open-angle glaucoma and cataracts. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Sight Sciences
 
Via Benzinga

Performance

YTD
-8.7%
-8.7%
1 Month
-5.5%
-5.5%
3 Month
-11.6%
-11.6%
6 Month
+35.7%
+35.7%
1 Year
-47.1%
-47.1%

More News

Read More
Earnings Scheduled For August 7, 2025
Via Benzinga
The Analyst Verdict: Sight Sciences In The Eyes Of 4 Experts
Via Benzinga
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
From Sight Sciences, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Breaking Down Sight Sciences: 6 Analysts Share Their Views
Via Benzinga
What 6 Analyst Ratings Have To Say About Sight Sciences
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
These stocks are moving in today's pre-market session
Via Chartmill
Expert Outlook: Sight Sciences Through The Eyes Of 5 Analysts
Via Benzinga
Where Sight Sciences Stands With Analysts
Via Benzinga
Sight Sciences: Q4 Earnings Insights
Via Benzinga
Sight Sciences's Earnings: A Preview
Via Benzinga
Where Sight Sciences Stands With Analysts
Via Benzinga
Earnings Scheduled For March 5, 2025
Via Benzinga
Top 3 Health Care Stocks You'll Regret Missing In November
Via Benzinga
SGHT Stock Earnings: Sight Sciences Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
SGHT Stock Earnings: Sight Sciences Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 7, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Sight Sciences, Inc. - Common Stock publicly traded?
Yes, Sight Sciences, Inc. - Common Stock is publicly traded.
What exchange does Sight Sciences, Inc. - Common Stock trade on?
Sight Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sight Sciences, Inc. - Common Stock?
The ticker symbol for Sight Sciences, Inc. - Common Stock is SGHT on the Nasdaq Stock Market
What is the current price of Sight Sciences, Inc. - Common Stock?
The current price of Sight Sciences, Inc. - Common Stock is 3.270
When was Sight Sciences, Inc. - Common Stock last traded?
The last trade of Sight Sciences, Inc. - Common Stock was at 10/13/25 10:02 AM ET
What is the market capitalization of Sight Sciences, Inc. - Common Stock?
The market capitalization of Sight Sciences, Inc. - Common Stock is 158.46M
How many shares of Sight Sciences, Inc. - Common Stock are outstanding?
Sight Sciences, Inc. - Common Stock has 158M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.